CAS: 913612-38-1

Brexpiprazole dihydrochloride is a drug that belongs to the group of antipsychotics. It is a partial agonist at serotonin receptors, with high affinity for 5HT2A and 5HT1A receptors. Brexpiprazole dihydrochloride has been shown to be effective in treating schizophrenia, bipolar disorder, and major depressive disorder. Brexpiprazole dihydrochloride is a prodrug that is converted by esterases into brexpiprazole, its active form. The conversion of brexpiprazole dihydrochloride to brexpiprazole occurs in the blood and the brain.

Brexpiprazole HCl (OPC 34712 dihydrochloride) is a new antipsychotic drug.

Brexpiprazole HCl